Report Detail

Medical Devices & Consumables Global Cancer Ablation Devices Market Research Report 2021

  • RnM4295020
  • |
  • 22 March, 2021
  • |
  • Global
  • |
  • 115 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

1 Cancer Ablation Devices Market Overview

  • 1.1 Product Overview and Scope of Cancer Ablation Devices
  • 1.2 Cancer Ablation Devices Segment by Type
    • 1.2.1 Global Cancer Ablation Devices Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Cryoablation
    • 1.2.3 High-Intensity Focused Ultrasound (HIFU)
    • 1.2.4 Laser Interstitial Thermal Therapy (LiTT)
    • 1.2.5 Microwave Ablation (MWA)
    • 1.2.6 Radiofrequency Ablation (RFA)
    • 1.2.7 Irreversible Electroporation (Ire)
    • 1.2.8 Non-Thermal Ablation
  • 1.3 Cancer Ablation Devices Segment by Application
    • 1.3.1 Cancer Ablation Devices Sales Comparison by Application: (2021-2027)
    • 1.3.2 Brain Cancer
    • 1.3.3 Brown
    • 1.3.4 Colorectal Cancer
    • 1.3.5 Kidney Cancer
    • 1.3.6 Liver Cancer
    • 1.3.7 Lung Cancer
    • 1.3.8 Pancreatic Cancer
    • 1.3.9 Prostate Cancer
  • 1.4 Global Cancer Ablation Devices Market Size Estimates and Forecasts
    • 1.4.1 Global Cancer Ablation Devices Revenue 2016-2027
    • 1.4.2 Global Cancer Ablation Devices Sales 2016-2027
    • 1.4.3 Cancer Ablation Devices Market Size by Region: 2016 Versus 2021 Versus 2027

2 Cancer Ablation Devices Market Competition by Manufacturers

  • 2.1 Global Cancer Ablation Devices Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Cancer Ablation Devices Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Cancer Ablation Devices Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Cancer Ablation Devices Manufacturing Sites, Area Served, Product Type
  • 2.5 Cancer Ablation Devices Market Competitive Situation and Trends
    • 2.5.1 Cancer Ablation Devices Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Cancer Ablation Devices Players Market Share by Revenue
    • 2.5.3 Global Cancer Ablation Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Cancer Ablation Devices Retrospective Market Scenario by Region

  • 3.1 Global Cancer Ablation Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.2 Global Cancer Ablation Devices Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.3 North America Cancer Ablation Devices Market Facts & Figures by Country
    • 3.3.1 North America Cancer Ablation Devices Sales by Country
    • 3.3.2 North America Cancer Ablation Devices Revenue by Country
    • 3.3.3 U.S.
    • 3.3.4 Canada
  • 3.4 Europe Cancer Ablation Devices Market Facts & Figures by Country
    • 3.4.1 Europe Cancer Ablation Devices Sales by Country
    • 3.4.2 Europe Cancer Ablation Devices Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Cancer Ablation Devices Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Cancer Ablation Devices Sales by Region
    • 3.5.2 Asia Pacific Cancer Ablation Devices Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
    • 3.5.12 Philippines
    • 3.5.13 Vietnam
  • 3.6 Latin America Cancer Ablation Devices Market Facts & Figures by Country
    • 3.6.1 Latin America Cancer Ablation Devices Sales by Country
    • 3.6.2 Latin America Cancer Ablation Devices Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
  • 3.7 Middle East and Africa Cancer Ablation Devices Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Cancer Ablation Devices Sales by Country
    • 3.7.2 Middle East and Africa Cancer Ablation Devices Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Cancer Ablation Devices Historic Market Analysis by Type

  • 4.1 Global Cancer Ablation Devices Sales Market Share by Type (2016-2021)
  • 4.2 Global Cancer Ablation Devices Revenue Market Share by Type (2016-2021)
  • 4.3 Global Cancer Ablation Devices Price by Type (2016-2021)

5 Global Cancer Ablation Devices Historic Market Analysis by Application

  • 5.1 Global Cancer Ablation Devices Sales Market Share by Application (2016-2021)
  • 5.2 Global Cancer Ablation Devices Revenue Market Share by Application (2016-2021)
  • 5.3 Global Cancer Ablation Devices Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 Alfresa Pharma Corp.
    • 6.1.1 Alfresa Pharma Corp. Corporation Information
    • 6.1.2 Alfresa Pharma Corp. Description and Business Overview
    • 6.1.3 Alfresa Pharma Corp. Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 Alfresa Pharma Corp. Product Portfolio
    • 6.1.5 Alfresa Pharma Corp. Recent Developments/Updates
  • 6.2 AngioDynamics, Inc.
    • 6.2.1 AngioDynamics, Inc. Corporation Information
    • 6.2.2 AngioDynamics, Inc. Description and Business Overview
    • 6.2.3 AngioDynamics, Inc. Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 AngioDynamics, Inc. Product Portfolio
    • 6.2.5 AngioDynamics, Inc. Recent Developments/Updates
  • 6.3 BTG plc (Galil Medical Ltd./Perseon Medical)
    • 6.3.1 BTG plc (Galil Medical Ltd./Perseon Medical) Corporation Information
    • 6.3.2 BTG plc (Galil Medical Ltd./Perseon Medical) Description and Business Overview
    • 6.3.3 BTG plc (Galil Medical Ltd./Perseon Medical) Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 BTG plc (Galil Medical Ltd./Perseon Medical) Product Portfolio
    • 6.3.5 BTG plc (Galil Medical Ltd./Perseon Medical) Recent Developments/Updates
  • 6.4 Biomedical S.r.l.
    • 6.4.1 Biomedical S.r.l. Corporation Information
    • 6.4.2 Biomedical S.r.l. Description and Business Overview
    • 6.4.3 Biomedical S.r.l. Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Biomedical S.r.l. Product Portfolio
    • 6.4.5 Biomedical S.r.l. Recent Developments/Updates
  • 6.5 Boston Scientific Corporation
    • 6.5.1 Boston Scientific Corporation Corporation Information
    • 6.5.2 Boston Scientific Corporation Description and Business Overview
    • 6.5.3 Boston Scientific Corporation Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Boston Scientific Corporation Product Portfolio
    • 6.5.5 Boston Scientific Corporation Recent Developments/Updates
  • 6.6 CSA Medical, Inc.
    • 6.6.1 CSA Medical, Inc. Corporation Information
    • 6.6.2 CSA Medical, Inc. Description and Business Overview
    • 6.6.3 CSA Medical, Inc. Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 CSA Medical, Inc. Product Portfolio
    • 6.6.5 CSA Medical, Inc. Recent Developments/Updates
  • 6.7 Chongqing Haifu Medical Technology Co., Ltd
    • 6.6.1 Chongqing Haifu Medical Technology Co., Ltd Corporation Information
    • 6.6.2 Chongqing Haifu Medical Technology Co., Ltd Description and Business Overview
    • 6.6.3 Chongqing Haifu Medical Technology Co., Ltd Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Chongqing Haifu Medical Technology Co., Ltd Product Portfolio
    • 6.7.5 Chongqing Haifu Medical Technology Co., Ltd Recent Developments/Updates
  • 6.8 ECO Medical
    • 6.8.1 ECO Medical Corporation Information
    • 6.8.2 ECO Medical Description and Business Overview
    • 6.8.3 ECO Medical Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 ECO Medical Product Portfolio
    • 6.8.5 ECO Medical Recent Developments/Updates
  • 6.9 EDAP TMS S.A.
    • 6.9.1 EDAP TMS S.A. Corporation Information
    • 6.9.2 EDAP TMS S.A. Description and Business Overview
    • 6.9.3 EDAP TMS S.A. Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 EDAP TMS S.A. Product Portfolio
    • 6.9.5 EDAP TMS S.A. Recent Developments/Updates
  • 6.10 HS Hospital Service S.p.A.
    • 6.10.1 HS Hospital Service S.p.A. Corporation Information
    • 6.10.2 HS Hospital Service S.p.A. Description and Business Overview
    • 6.10.3 HS Hospital Service S.p.A. Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 HS Hospital Service S.p.A. Product Portfolio
    • 6.10.5 HS Hospital Service S.p.A. Recent Developments/Updates
  • 6.11 IceCure Medical, Inc.
    • 6.11.1 IceCure Medical, Inc. Corporation Information
    • 6.11.2 IceCure Medical, Inc. Cancer Ablation Devices Description and Business Overview
    • 6.11.3 IceCure Medical, Inc. Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 IceCure Medical, Inc. Product Portfolio
    • 6.11.5 IceCure Medical, Inc. Recent Developments/Updates
  • 6.12 Johnson & Johnson (Ethicon, Inc.)
    • 6.12.1 Johnson & Johnson (Ethicon, Inc.) Corporation Information
    • 6.12.2 Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Description and Business Overview
    • 6.12.3 Johnson & Johnson (Ethicon, Inc.) Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.12.4 Johnson & Johnson (Ethicon, Inc.) Product Portfolio
    • 6.12.5 Johnson & Johnson (Ethicon, Inc.) Recent Developments/Updates
  • 6.13 Kang-Yu Medical Co., Ltd.
    • 6.13.1 Kang-Yu Medical Co., Ltd. Corporation Information
    • 6.13.2 Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Description and Business Overview
    • 6.13.3 Kang-Yu Medical Co., Ltd. Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.13.4 Kang-Yu Medical Co., Ltd. Product Portfolio
    • 6.13.5 Kang-Yu Medical Co., Ltd. Recent Developments/Updates
  • 6.14 MedLink Technologies LLC
    • 6.14.1 MedLink Technologies LLC Corporation Information
    • 6.14.2 MedLink Technologies LLC Cancer Ablation Devices Description and Business Overview
    • 6.14.3 MedLink Technologies LLC Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.14.4 MedLink Technologies LLC Product Portfolio
    • 6.14.5 MedLink Technologies LLC Recent Developments/Updates
  • 6.15 MedWaves, Inc.
    • 6.15.1 MedWaves, Inc. Corporation Information
    • 6.15.2 MedWaves, Inc. Cancer Ablation Devices Description and Business Overview
    • 6.15.3 MedWaves, Inc. Cancer Ablation Devices Sales, Revenue and Gross Margin (2016-2021)
    • 6.15.4 MedWaves, Inc. Product Portfolio
    • 6.15.5 MedWaves, Inc. Recent Developments/Updates

7 Cancer Ablation Devices Manufacturing Cost Analysis

  • 7.1 Cancer Ablation Devices Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Cancer Ablation Devices
  • 7.4 Cancer Ablation Devices Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Cancer Ablation Devices Distributors List
  • 8.3 Cancer Ablation Devices Customers

9 Cancer Ablation Devices Market Dynamics

  • 9.1 Cancer Ablation Devices Industry Trends
  • 9.2 Cancer Ablation Devices Growth Drivers
  • 9.3 Cancer Ablation Devices Market Challenges
  • 9.4 Cancer Ablation Devices Market Restraints

10 Global Market Forecast

  • 10.1 Cancer Ablation Devices Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Cancer Ablation Devices by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Cancer Ablation Devices by Type (2022-2027)
  • 10.2 Cancer Ablation Devices Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Cancer Ablation Devices by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Cancer Ablation Devices by Application (2022-2027)
  • 10.3 Cancer Ablation Devices Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Cancer Ablation Devices by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Cancer Ablation Devices by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Cryoablation
    High-Intensity Focused Ultrasound (HIFU)
    Laser Interstitial Thermal Therapy (LiTT)
    Microwave Ablation (MWA)
    Radiofrequency Ablation (RFA)
    Irreversible Electroporation (Ire)
    Non-Thermal Ablation

    Segment by Application
    Brain Cancer
    Brown
    Colorectal Cancer
    Kidney Cancer
    Liver Cancer
    Lung Cancer
    Pancreatic Cancer
    Prostate Cancer

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    Alfresa Pharma Corp.
    AngioDynamics, Inc.
    BTG plc (Galil Medical Ltd./Perseon Medical)
    Biomedical S.r.l.
    Boston Scientific Corporation
    CSA Medical, Inc.
    Chongqing Haifu Medical Technology Co., Ltd
    ECO Medical
    EDAP TMS S.A.
    HS Hospital Service S.p.A.
    IceCure Medical, Inc.
    Johnson & Johnson (Ethicon, Inc.)
    Kang-Yu Medical Co., Ltd.
    MedLink Technologies LLC
    MedWaves, Inc.


    Summary:
    Get latest Market Research Reports on Cancer Ablation Devices. Industry analysis & Market Report on Cancer Ablation Devices is a syndicated market report, published as Global Cancer Ablation Devices Market Research Report 2021. It is complete Research Study and Industry Analysis of Cancer Ablation Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $2,900.00
    $4,350.00
    $5,800.00
    2,097.28
    3,145.92
    4,194.56
    2,419.04
    3,628.56
    4,838.08
    315,609.90
    473,414.85
    631,219.80
    216,474.56
    324,711.84
    432,949.12
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report